Referred to the Committee on Education and Workforce, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each c…
This bill creates a federal pilot grant program administered by HHS, in consultation with the Department of Education, funding school–public health partnerships to prevent synthetic opioid misuse and support recovery among secondary school-aged youth.
It establishes an interagency task force, requires school personnel training and ESEA plan amendments, expands data collection (surveys and NCES reporting), permits naloxone purchases in school-based health centers, and mandates program reporting and independent evaluation.
Grants (up to 25, three-year awards) fund evidence-based prevention, training, peer support, communications, and recovery services; funds are authorized as “such sums as necessary” for FY2026–2028.
Content is administratively focused and broadly sympathetic, but requires appropriations and cross‑committee approvals which add uncertainty.
Relative to its intended legislative type, this bill is a coherent substantive policy package that establishes a competitive grant pilot, creates an interagency task force with defined membership and duties, amends existing education and public-health statutes for training and data collection, and embeds reporting and evaluation requirements; it balances clear statutory insertions with administrative discretion for implementation.
Progressives emphasize public-health, equity, and naloxone access.
Progressives emphasize public-health, equity, and naloxone access.
Likely broadly supportive: frames the bill as a public-health, equity-focused response to youth fentanyl risk and school-based prevention.
Would welcome naloxone availability, culturally responsive materials, peer recovery services, and outreach to underserved communities, while urging robust funding and non-punitive implementation.
Generally favorable if evidence-driven and fiscally accountable: appreciates coordination between HHS and Education, emphasis on evaluation, and data improvements.
Concerned about cost transparency, measurable outcomes, and avoiding overlap with existing programs.
Cautious to skeptical: supports protecting children from drugs and naloxone availability, but worries about increased federal involvement in school curriculum, data collection, and potential mission creep.
Would press for limited federal authority, local control, and fiscal restraint.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content is administratively focused and broadly sympathetic, but requires appropriations and cross‑committee approvals which add uncertainty.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize public-health, equity, and naloxone access.
Content is administratively focused and broadly sympathetic, but requires appropriations and cross‑committee approvals which add uncertaint…
Relative to its intended legislative type, this bill is a coherent substantive policy package that establishes a competitive grant pilot, creates an interagency task force with defined membership and duties, amends exis…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.